DOPAMINE D-3 AND D-4 RECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF -4-[(CYCLOPROPYLCARBONYL)AMINO]-2-METHOXYBENZAMIDE (YM-43611) AND RELATED-COMPOUNDS())
J. Ohmori et al., DOPAMINE D-3 AND D-4 RECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF -4-[(CYCLOPROPYLCARBONYL)AMINO]-2-METHOXYBENZAMIDE (YM-43611) AND RELATED-COMPOUNDS()), Journal of medicinal chemistry, 39(14), 1996, pp. 2764-2772
In this study, we synthesized a series of (S)-N-(3-pyrrolidinyl)benzam
ide derivatives, 1, 2a-d, 5a-1, and 7, and their enantiomers, (R)-1 an
d (R)-5c-e, and evaluated their binding affinity for cloned dopamine D
-2, D-3, and D-4 receptors and their inhibitory activity against apomo
rphine-induced climbing behavior in mice. The results indicate that D-
2, D-3, and D-4 receptors have different bulk tolerance (D-4 > D-3 > D
-2) for the substituent of the 4-amino group (R(1)) on the benzamide n
uclei and that cyclopropyl-, cyclobutyl-, and cyclopentylcarbonyl grou
ps likely possess adequate bulkiness with respect to D-3 and D-4 affin
ity and selectivity over D-2 receptors in this series. The results als
o suggested that the N-substituent (R(2)) On the pyrrolidin-3-yl group
performs an important role in expressing affinity for D-2, D-3, and D
-4 receptors and selectivity among the respective subtypes. One of the
compounds, -4-[(cyclopropylcarbonyl)amino]-2-methoxybenzamide (5c) (Y
M-43611), showed high affinity for D-3 and D-4 receptors (K-i values o
f 21 and 2.1 nM, respectively) with 110-fold D-4 selectivity and 10-fo
ld D-3 preference over D-2 receptors and weak or negligible affinity f
or representative neurotransmitter receptors. Compound 5c displayed po
tent antipsychotic activity in inhibiting apomorphine-induced climbing
behavior in mice (ED(50) value, 0.32 mg/kg sc).